Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: November 29, 2021

DrugPatentWatch Database Preview

Patent: 9,561,266

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,561,266
Title:Target peptides for immunotherapy and diagnostics
Abstract: A set of target peptides are presented by HLA A*0101, A*0201, A*0301, B*4402, B*2705, B*1402, and B*0702 on the surface of disease cells. They are envisioned to among other things (a) stimulate an immune response to the proliferative disease, e.g., cancer, (b) to function as immunotherapeutics in adoptive T cell therapy or as a vaccine, (c) facilitate antibody recognition of tumor boundaries in surgical pathology samples, (d) act as biomarkers for early detection and/or diagnosis of the disease, and (e) act as targets in the generation antibody-like molecules which recognize the target-peptide/MHC complex.
Inventor(s): Hunt; Donald F. (Charlottesville, VA), Shabanowitz; Jeffrey (Charlottesville, VA), Malaker; Stacy A. (Charlottesville, VA), Engelhard; Victor H. (Crozet, VA), Zarling; Angela (Richmond, VA), Cummings; Kara L. (Charlottesville, VA), Obeng; Rebecca C. (Charlottesville, VA), Cobbold; Mark (Birmingham, GB)
Assignee: University of Virginia Patent Foundation (Charlottesville, VA) The University of Birmingham (Birmingham, GB)
Application Number:14/424,702
Patent Claims:see list of patent claims

Details for Patent 9,561,266

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Organon Teknika Corporation Llc TICE BCG bcg live For Injection 102821 1989-06-21 ⤷  Try it Free 2032-08-31
Bristol-myers Squibb Company YERVOY ipilimumab Injection 125377 2011-03-25 ⤷  Try it Free 2032-08-31
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.